Skip to product information
1 of 3

Quicksilver Scientific

BPC-157 + KPV Combo (1 fl oz / 30 ml)

BPC-157 + KPV Combo (1 fl oz / 30 ml)

A liposomal dual-peptide formula combining BPC-157 and KPV to support gastrointestinal barrier integrity, NF-κB-mediated anti-inflammatory activity, angiogenic tissue repair, and antimicrobial immune modulation with superior mucosal bioavailability.
  • Size:   1 fl oz (30 mL)
  • Manufacturer:   Quicksilver Scientific
  • SKU:   QS-BCP_KPV
  • Stock status:   20
Shipping calculated at checkout.

Practitioners log in to see prices & availability

View full details

What it is: BPC-157 + KPV Liposomal Peptide is a professional-grade, dual-action oral peptide formula developed by Quicksilver Scientific, delivering 500 mcg each of BPC-157 and KPV per 0.5 ml pump serving in an advanced liposomal phospholipid delivery system designed for superior mucosal absorption and rapid systemic bioavailability. BPC-157 (Body Protection Compound 157) is a 15-amino acid synthetic peptide derived from the BPC protein naturally present in the human gastric mucosa, recognized for its regenerative, angiogenic, and gastrointestinal protective activity. KPV is a naturally occurring tripeptide composed of lysine (K), proline (P), and valine (V) — representing the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH) — with potent anti-inflammatory and antimicrobial properties that are independent of the melanogenic effects associated with the full α-MSH molecule. Delivered in Quicksilver Scientific's patented liposomal technology utilizing highly purified phospholipids and tocofersolan for enhanced mucosal and cellular uptake, this formula is designed for integration into practitioner-directed protocols targeting gastrointestinal integrity, inflammatory modulation, tissue repair, immune balance, and antimicrobial support.

How it works: BPC-157 + KPV supports gastrointestinal, systemic inflammatory, and tissue repair health through the complementary and synergistic mechanisms of its two constituent peptides, each operating through distinct intracellular signaling pathways. BPC-157 (500 mcg per serving) exerts its primary activity through upregulation of the nitric oxide (NO) system and modulation of the VEGF (vascular endothelial growth factor) pathway, promoting angiogenesis — the formation of new blood vessels essential for tissue healing and repair — in gastrointestinal mucosa, tendons, ligaments, muscle, bone, and neural tissue. BPC-157 supports gastrointestinal lining integrity by protecting and restoring the epithelial barrier from damage, counteracting the damaging effects of NSAIDs, alcohol, and other mucosal irritants through its cytoprotective activity in gastric and intestinal epithelium. Emerging research highlights BPC-157's neuroprotective potential through its modulation of dopaminergic and serotonergic neurotransmitter systems, and its support for neurovascular blood flow. KPV (500 mcg per serving) exerts its anti-inflammatory effects through direct intracellular pathways that are independent of melanocortin receptor (MC-R) binding — specifically through inhibition of pro-inflammatory transcription factor NF-κB and downstream suppression of IL-6, IL-8, TNF-α, and other pro-inflammatory cytokine cascades. KPV directly enters immune cells and intestinal epithelial cells to suppress inflammatory signaling from within, providing localized gut anti-inflammatory activity alongside systemic immune modulation. KPV additionally demonstrates antimicrobial activity against a range of pathogens relevant to gastrointestinal and systemic health, and supports gut barrier epithelial integrity through its epithelial cell-protective and tight junction-supporting mechanisms. The liposomal delivery system encapsulates both peptides within phospholipid vesicles that protect them from enzymatic degradation in the gastrointestinal tract, facilitate absorption across mucosal membranes during sublingual hold, and enable efficient cellular uptake — dramatically improving the systemic bioavailability of these orally administered peptides compared to unformulated aqueous peptide preparations.

When to use it: BPC-157 + KPV Liposomal Peptide is appropriate for practitioner-directed use in adult clients requiring targeted support for gastrointestinal barrier integrity, systemic and gut-localized inflammatory modulation, tissue repair across gastrointestinal, connective, vascular, and neural tissue compartments, and antimicrobial immune support. It is particularly well-suited for integration into protocols addressing inflammatory bowel conditions, leaky gut and intestinal permeability, post-antibiotic gut restoration, musculoskeletal tissue repair, neurological inflammatory burden, and metabolically driven inflammatory recovery. One pump (0.5 ml) taken sublingually one to two times daily — held in the mouth for 30–90 seconds before swallowing on an empty stomach — supports optimal mucosal and systemic peptide absorption. This product requires refrigeration upon receipt. For professional use only; not recommended during pregnancy or nursing without healthcare practitioner consultation.

Serving Size: 1 Pump (0.5 ml)

Servings Per Container: 60

Suggested Use: Take 1 pump by mouth. Hold in mouth for 30–90 seconds before swallowing. Repeat to desired dosage or as directed by your healthcare practitioner. Best taken on an empty stomach.

Ingredient

Amount Per Serving

% Daily Value

BPC-157 (Body Protection Compound 157)

500 mcg

KPV (Lys-Pro-Val Tripeptide)

500 mcg

† Daily Value not established.

Other Ingredients: Water, glycerin, ethanol, highly purified phospholipids, tocofersolan, natural mixed tocopherols.

Caution: For professional use only. Consult your healthcare practitioner prior to use if pregnant, nursing, or taking medications. Keep out of reach of children. Do not use if tamper-evident seal is broken or missing. Refrigerate upon receipt.

✓ Gluten Free ✓ Dairy Free ✓ Soy Free ✓ Non-GMO ✓ No Artificial Colors or Preservatives

Key Ingredients

BPC-157 (Body Protection Compound 157) — 500 mcg BPC-157 is a 15-amino acid synthetic pentadecapeptide derived from the body protection compound (BPC) protein naturally secreted in the human gastric mucosa — a region of exceptionally robust regenerative capacity — where endogenous BPC plays a cytoprotective role in maintaining gastrointestinal lining integrity under conditions of chemical, mechanical, and oxidative stress. Its primary regenerative mechanism involves upregulation of the nitric oxide (NO) signaling system and VEGF-mediated angiogenesis — the formation of new capillary networks essential for delivering oxygen, nutrients, and growth factors to healing tissue — with demonstrated activity supporting mucosal repair in the stomach and intestine, tendon and ligament regeneration, muscle fiber repair, bone healing, and neurovascular restoration. BPC-157 additionally modulates the dopaminergic and serotonergic neurotransmitter systems with emerging neuroprotective implications, and counteracts the damaging mucosal effects of NSAIDs and alcohol through its direct epithelial cytoprotective and tight junction-stabilizing activity — establishing it as the formula's primary angiogenic, regenerative, and gastrointestinal barrier-protective peptide component.

KPV (Lys-Pro-Val Tripeptide) — 500 mcg KPV is a naturally occurring C-terminal tripeptide sequence of alpha-melanocyte-stimulating hormone (α-MSH) — composed of lysine (K), proline (P), and valine (V) — that retains the potent anti-inflammatory and antimicrobial properties of the parent α-MSH molecule while being entirely devoid of its melanogenic (skin-darkening) effects, as these functions are mediated through distinct molecular mechanisms. KPV exerts its primary anti-inflammatory activity through direct intracellular penetration of immune cells and intestinal epithelial cells, where it inhibits the NF-κB transcription factor complex — the master regulator of pro-inflammatory gene expression — independently of melanocortin receptor binding, resulting in downstream suppression of IL-6, IL-8, TNF-α, and other key inflammatory cytokines through a receptor-independent intracellular mechanism. At the gastrointestinal level, KPV directly supports intestinal epithelial barrier integrity through its epithelial cell-protective activity and promotion of tight junction protein expression, while simultaneously exerting antimicrobial activity against a spectrum of gut-relevant pathogens — establishing it as the formula's primary immune-modulatory, anti-inflammatory, antimicrobial, and gut epithelial-protective peptide component, synergistic with BPC-157's angiogenic and regenerative mechanisms across the full arc of gastrointestinal and systemic tissue health support.